Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.

Strewler, Gordon J; Stern, P.; Jacobs, John; Eveloff, Jill; Klein, Robert F.; Leung, Shing-Chi; Rosenblatt, Michael; Nissenson, Robert A.

doi:10.1172/jci113275

Cited by 515 publications

(172 citation statements)

References 20 publications

(19 reference statements)

Supporting

Mentioning

162

Contrasting

Unclassified

Order By: Relevance

“…[1][2][3] The first 13 amino acids of PTHrP and parathyroid hormone (PTH) share significant homology 4,5 and it is this sequence which interacts with the parathyroid hormone receptor 1 (PTHR1). 6 As a result, tumour-derived PTHrP enters the circulation and activates PTHR1 in both the bone and kidney to induce PTH-like activity, the outcome of which is hypercalcaemia and osteoclast-mediated bone resorption.…”

mentioning

confidence: 99%

Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells

Kumari

Robertson

Watson

2006

Intl Journal of Cancer

View full text Add to dashboard Cite

Parathyroid-hormone related protein (PTHrP) is the primary factor in humoral hypercalcemia of malignancy and is highly secreted by breast cancers. The pro-hormone undergoes posttranslational processing and cleavage to give rise to mature secretory peptides, one of which is midregion PTHrP (38-94/95/101) containing a nuclear localisation sequence (NLS) in amino acids (87)(88)(89)(90)(91)(92)(93)(94)(95)(96)(97)(98)(99)(100)(101)(102)(103)(104)(105)(106). The current study investigates whether the NLS in midregion PTHrP is important in breast cancer growth. PTHrP-(67-101), a midregion PTHrP fragment containing NLS-(87-101) significantly increased growth of MCF-7 and MDA-MB231 cells (126.3 and 121.3% of control respectively in serum conditions), independent of PTHR1 whereas PTHrP-(67-86), which lacks the NLS did not. Fluorescent-labelled PTHrP-(67-101) translocated to the nucleus, whereas PTHrP-(67-86) remained cytosolic and a scrambled(1NLS) peptide was not internalised. In comparison, no growth influence or uptake was seen in non-tumour breast cells (Hs578Bst). Increases in intracellular calcium mobilisation were observed in breast cancer cells stimulated with both PTHrP-(67-101) and PTHrP-(67-86) (EC 50 of 3.2 pM and 2.2 pM respectively for MCF-7 cells), whereas inositide turnover was not detected. Both nuclear uptake and calcium signalling were attenuated in the presence of EGTA, but not with U73122 or N-terminal PTHrP peptides. Our studies indicate that the NLS-containing midregion PTHrP peptide is dependent on both internalisation and nuclear translocation to induce growth in breast cancer cells. These findings highlight the importance of midregion PTHrP and its receptor in breast cancer growth and may provide potential targets for future therapeutic intervention. ' 2006 Wiley-Liss, Inc.Key words: PTHrP; breast cancer; NLS; calcium signalling; midregion PTHrP Parathyroid hormone-related protein (PTHrP) was first identified as a tumour-derived protein that was the primary factor in humoral hypercalcemia of malignancy (HHM). 1-3 The first 13 amino acids of PTHrP and parathyroid hormone (PTH) share significant homology 4,5 and it is this sequence which interacts with the parathyroid hormone receptor 1 (PTHR1). 6 As a result, tumour-derived PTHrP enters the circulation and activates PTHR1 in both the bone and kidney to induce PTH-like activity, the outcome of which is hypercalcaemia and osteoclast-mediated bone resorption. 1,2,7 PTHrP is expressed in breast epithelium and is associated with normal mammary gland function, cell growth and differentiation. [8][9][10][11][12] Studies using PTHrP knockout mice resulted in mammary epithelial cell degeneration, 13 emphasising the importance of PTHrP in breast growth. Breast cancers, in most cases, secrete high levels of PTHrP, [14][15][16] and as a result malignancy associated HHM is very common. The expression of PTHrP has also been reported to be higher in breast cancer skeletal metastases than in the primary tumour. 14,17,18 The role of PTHrP may therefore be biolog...

show abstract

mentioning

confidence: 99%

Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells

Kumari

Robertson

Watson

2006

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…In SMRC-1, the number of chromosomes varied from 92 to 100 and the modal number was 95. The representative G-banded karyotype was 95~99 < 4n >, XXYY, +1 [7], +1 [3], add(1)(p36) [8], add(1) [6], der(1;3)(q10;p10) [9], der(1;3) [7], +2 [7], -3 [8], -3 [4], add(3)(q13) [4], del(3)(q27) [7], del (3) [3], +8~21mar. In SMRC-3, the number of chromosomes varied from 42 to 47 and the modal number was 45.…”

Section: Resultsmentioning

confidence: 99%

“…1,2 Parathyroid hormonerelated protein was originally isolated, 3,4 cloned and sequenced 5,6 from tumors associated with hypercalcemia and has been identified in a variety of adult and fetal tissues. The human PTHrP gene is located on the short arm of chromosome 12 and consists of nine exons, of which two are present in all PTHrP transcripts: exon V, encoding the prepro region of the protein and exon VI, which encodes the mature protein up to residue 139.…”

Section: Introductionmentioning

confidence: 99%

Production of parathyroid hormone‐related protein in two new cell lines of renal cell carcinoma

et al. 2001

View full text Add to dashboard Cite

Background: Hypercalcemia is the most common of all paraneoplastic syndromes and has been reported to appear in up to 20% of patients with renal cell carcinoma (RCC). Humoral hypercalcemia of malignancy is believed to be induced when parathyroid hormone-related protein (PTHrP) is excessively produced in cancer cells and impairs the homeostasis of serum calcium concentrations.Methods: Cancer cells were isolated from a surgical specimen and successfully cultured in a monolayer. The present study describes the establishment and characterization of new cell lines of RCC.Results: Two different cell lines, designated SMRC-1 and SMRC-3, were established from human RCC, each of which had been continuously secreting PTHrP in vitro. The patient from whom the SMRC-3 cells were obtained was shown to have elevated levels of PTHrP and resultant hypercalcemia. Cultured SMRC-1 was spindle-shaped in morphology. SMRC-3 had pleomorphic polygonal shapes and formed typical epithelial monolayers. Both cell types secreted intact, C-terminal PTHrP and interleukin-6 in the culture medium. Cellular messenger RNA of PTHrP was analyzed by reverse transcriptase-polymerase chain reaction. The SMRC-1 cells showed chromosome numbers ranging from 42 to 47 with consistent structural abnormalities of add(4)(q23~25) and add(6)(q13). The chromosomal analysis of SMRC-3 revealed a modal number of 95 with consistent structural abnormalities of add(1)(p36) and der(1;3)(q10;p10). Conclusions: These cell lines could be good models for investigating the mechanism of PTHrP production and the relationship between this hormone and hypercalcemia.

show abstract

“…Furthermore, by using rabbit anti-mid-region PTHrP, we specifically revealed a single band of approximately 7 kDa related to the mid-region, as described for other tumors. (9)(10)(11)(23)(24)(25) We also measured RNA levels of both PTHrP and PTH-R1 (Fig. 1D) in selected plasma cell samples, based on the highest cytometric expression.…”

Section: Calcium and Pthrp Serum Levelsmentioning

confidence: 99%

“…(7,8) PTHrP has been primarily reported in patients with osteotropic malignancies, such as breast, lung, and renal cancers, who show skeletal disease and hypercalcemia. (9)(10)(11)(12) Subsequent studies have described its functional effects through either paracrine or autocrine cell stimulation by tumors with no skeleton involvement and even by several normal tissues. (13)(14)(15) An intracrine effect of PTHrP has been also postulated in breast cancer to improve the nucleocytoplasmic trafficking that accelerates cell cycle progression, RNA transcription, and transport.…”

Section: Introductionmentioning

confidence: 99%

PTHrP Produced by Myeloma Plasma Cells Regulates Their Survival and Pro-Osteoclast Activity For Bone Disease Progression

Cafforio

Savonarola

Stucci

et al. 2013

Journal of Bone and Mineral Research

View full text Add to dashboard Cite

To promote their survival and progression in the skeleton, osteotropic malignancies of breast, lung, and prostate produce parathyroid hormone-related protein (PTHrP), which induces hypercalcemia. PTHrP serum elevations have also been described in multiple myeloma (MM), although their role is not well defined. When we investigated MM cells from patients and cell lines, we found that PTHrP and its receptor (PTH-R1) are highly expressed, and that PTHrP is secreted both as a full-length molecule and as small subunits. Among these subunits, the mid-region, including the nuclear localization sequence (NLS), exerted a proliferative effect because it was accumulated in nuclei of MM cells surviving in starvation conditions. This was confirmed by increased transcription of several genes enrolled in proliferation and apoptosis control. PTHrP was also found to stimulate PTH-R1 in MM cells. PTH-R1's selective activation by the full-length PTHrP molecule or the NH 2 -terminal fragment resulted in a significant increase of intracellular Ca 2þ influx, cyclic adenosine monophosphate (cAMP) content, and expression of receptor activator of NF-kB ligand (RANKL) and monocyte chemoattractant protein-1 (MCP-1). Our data definitely clarify the role of PTHrP in MM. The PTHrP peptide is functionally secreted by malignant plasma cells and contributes to MM tumor biology and progression, both by intracrine maintenance of cell proliferation in stress conditions and by autocrine or paracrine stimulation of PTH-R1, which in turn reinforces the production of osteoclastogenic factors.

show abstract

Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.

Cited by 515 publications

References 20 publications

Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells

Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells

Production of parathyroid hormone‐related protein in two new cell lines of renal cell carcinoma

PTHrP Produced by Myeloma Plasma Cells Regulates Their Survival and Pro-Osteoclast Activity For Bone Disease Progression

Contact Info

Product

Resources

About